Clinical Trial Update: Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Arestin (minocycline microspheres) for peri-implantitis has completed, including subgingival microbiological evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peri-implantitis

Drugs mentioned

• ARESTIN (MINOCYCLINE HYDROCHLORIDE)

Snippet

Sponsor: OraPharma | Conditions: Peri-Implantitis | Phase 3 | Status: COMPLETED